SE8305123D0 - Biologiskt aktiva tripeptid- och tetrapeptid-alkylamider, sett for framstellning derav och farmaceutiska kompositioner innehallande desamma - Google Patents

Biologiskt aktiva tripeptid- och tetrapeptid-alkylamider, sett for framstellning derav och farmaceutiska kompositioner innehallande desamma

Info

Publication number
SE8305123D0
SE8305123D0 SE8305123A SE8305123A SE8305123D0 SE 8305123 D0 SE8305123 D0 SE 8305123D0 SE 8305123 A SE8305123 A SE 8305123A SE 8305123 A SE8305123 A SE 8305123A SE 8305123 D0 SE8305123 D0 SE 8305123D0
Authority
SE
Sweden
Prior art keywords
alkylamides
tetrapeptide
carbon atoms
preparation
pharmaceutical compositions
Prior art date
Application number
SE8305123A
Other languages
English (en)
Other versions
SE8305123L (sv
SE457087B (sv
Inventor
E Kasafirek
P Fric
J Slaby
A Roubalova
Original Assignee
Spofa Vereinigte Pharma Werke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spofa Vereinigte Pharma Werke filed Critical Spofa Vereinigte Pharma Werke
Publication of SE8305123D0 publication Critical patent/SE8305123D0/sv
Publication of SE8305123L publication Critical patent/SE8305123L/sv
Publication of SE457087B publication Critical patent/SE457087B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1021Tetrapeptides with the first amino acid being acidic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0804Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
SE8305123A 1982-10-01 1983-09-22 Biologiskt aktiva tripeptid- och tetrapeptid-alkylamider och farmaceutiska kompositioner innehaallande desamma SE457087B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS827013A CS231228B1 (en) 1982-10-01 1982-10-01 Biologically effective tri and tetrapeptide alkylamide derivatives and their processing method

Publications (3)

Publication Number Publication Date
SE8305123D0 true SE8305123D0 (sv) 1983-09-22
SE8305123L SE8305123L (sv) 1984-04-02
SE457087B SE457087B (sv) 1988-11-28

Family

ID=5418471

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8305123A SE457087B (sv) 1982-10-01 1983-09-22 Biologiskt aktiva tripeptid- och tetrapeptid-alkylamider och farmaceutiska kompositioner innehaallande desamma

Country Status (13)

Country Link
US (1) US4528133A (sv)
JP (1) JPS5978150A (sv)
BE (1) BE897844A (sv)
CA (1) CA1243306A (sv)
CH (1) CH658251A5 (sv)
CS (1) CS231228B1 (sv)
DE (1) DE3335865A1 (sv)
FR (1) FR2533920B1 (sv)
GB (1) GB2127830B (sv)
HU (1) HU193048B (sv)
IT (1) IT1171092B (sv)
SE (1) SE457087B (sv)
YU (1) YU195383A (sv)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5444042A (en) * 1990-12-28 1995-08-22 Cortex Pharmaceuticals Method of treatment of neurodegeneration with calpain inhibitors
IL108031A0 (en) * 1992-12-22 1994-04-12 Procter & Gamble Difluoro pentapeptide derivatives and pharmaceutical compositions containing them
CZ285911B6 (cs) * 1997-04-30 1999-11-17 Vúfb, A. S. Oligopeptidické inhibitory elastáz
JP2000256396A (ja) 1999-03-03 2000-09-19 Dainippon Pharmaceut Co Ltd 複素環式化合物およびその中間体ならびにエラスターゼ阻害剤
PL354122A1 (en) * 1999-08-09 2003-12-29 Tripep Abtripep Ab Pharmaceutical compositions containing tripeptides
DE60023931T2 (de) * 1999-10-18 2006-08-03 Firmenich S.A. Ester mit einer sekundären carbamoylgruppe und deren verwendung als ausgangsstoffe von duftenden alkoholen
US6593455B2 (en) * 2001-08-24 2003-07-15 Tripep Ab Tripeptide amides that block viral infectivity and methods of use thereof
WO2003024995A1 (en) * 2001-09-19 2003-03-27 Tripep Ab Molecules that block viral infectivity and methods of use thereof
US20050096319A1 (en) * 2003-02-21 2005-05-05 Balzarini Jan M.R. Identification of compounds that inhibit replication of human immunodeficiency virus
US20040180893A1 (en) * 2003-02-21 2004-09-16 Balzarini Jan Maria Rene Identification of compounds that inhibit replication of human immunodeficiency virus
US20170043197A1 (en) * 2014-09-16 2017-02-16 Massachusetts Institute Of Technology Block Copolymer Complex Coacervate Core Micelles for Enzymatic Catalysis in Organic Solvent
BR112018076309A8 (pt) 2016-06-17 2022-06-28 Univ Erasmus Med Ct Rotterdam Compostos de geminóide e seus usos
WO2022235051A1 (ko) 2021-05-03 2022-11-10 한국화학연구원 에스테르 작용기를 포함하는 유색 고분자로부터 색을 발현하는 이물질을 제거하기 위한 추출제, 추출 방법 및 유색 고분자 혼합물로부터 에스테르 작용기를 포함하는 고분자를 화학적으로 선별하는 방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3972773A (en) * 1975-04-29 1976-08-03 Sagami Chemical Research Center Process for producing peptide
PH14141A (en) * 1976-06-25 1981-03-05 Hoffmann La Roche Pharmaceutical composition containing dipeptide derivatives
US4167449A (en) * 1976-07-29 1979-09-11 American Hospital Supply Corporation Composition and method for determining transferase and protease activity
US4155916A (en) * 1977-08-29 1979-05-22 Dolbeare Frank A Fluorescence method for enzyme analysis which couples aromatic amines with aromatic aldehydes
US4276298A (en) * 1978-03-24 1981-06-30 Merck & Co., Inc. 2-Aryl-1,2-benzisothiazolinone-1,1-dioxides and their use as selective protease inhibitors
US4336186A (en) * 1978-08-03 1982-06-22 Gargiulo Robert J Analytical fluorogenic substrates for proteolytic enzymes
US4275153A (en) * 1978-08-03 1981-06-23 American Hospital Supply Corporation Analytical fluorogenic substrates for proteolytic enzymes
CS226907B1 (en) * 1981-08-07 1984-04-16 Kasafirek Evzen Alkylamides of carboxyalkanoylpeptides
US4371466A (en) * 1981-10-07 1983-02-01 American Home Products Corporation Mammalian collagenase inhibitors

Also Published As

Publication number Publication date
JPH0359919B2 (sv) 1991-09-12
YU195383A (en) 1986-08-31
IT8323059A1 (it) 1985-03-29
SE8305123L (sv) 1984-04-02
DE3335865C2 (sv) 1991-03-14
HU193048B (en) 1987-08-28
SE457087B (sv) 1988-11-28
CS231228B1 (en) 1984-10-15
GB8324970D0 (en) 1983-10-19
GB2127830B (en) 1986-08-13
FR2533920A1 (fr) 1984-04-06
JPS5978150A (ja) 1984-05-04
BE897844A (fr) 1984-01-16
CH658251A5 (de) 1986-10-31
CA1243306A (en) 1988-10-18
DE3335865A1 (de) 1984-04-05
GB2127830A (en) 1984-04-18
IT8323059A0 (it) 1983-09-29
FR2533920B1 (fr) 1986-08-14
US4528133A (en) 1985-07-09
IT1171092B (it) 1987-06-10

Similar Documents

Publication Publication Date Title
SE8305123L (sv) Biologiskt aktiva tripeptid- och tetrapeptid-alkylamider, sett for framstellning derav och farmaceutiska kompositioner innehallande desamma
IE801342L (en) Peptides
BR0115447A (pt) Inibidores de tripeptìdeo de hepatite c
KR910000613A (ko) 피발산의 p-치환된 페닐 에스테르 유도체, 그의 제조방법 및 이를 포함하는 조성물
ID21956A (id) Asam n-(aril dan atau heteroarilasetil) amino ester, komposisi farmasi yang mengandungnya, dan metoda untuk menghambat pelepasan betha-amiloid peptida dan atau sintesanya dengan menggunakan senyawa tersebut
ATE59296T1 (de) Zusammensetzungen zur bekaempfung von toxaemia.
DE69521615D1 (de) Streptogramine in gereinigter form, ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen
JPS57212157A (en) Collagenase inhibitory compound
DE59002863D1 (de) Lysolecithinderivate zur behandlung von autoimmunerkrankungen.
FI945975A0 (sv) Tiazoler substituerade med en förgrenad aminogrupp, förfaranden för framställning av dessa och farmaceutiska kompositioner innehållande dessa
IE812974L (en) Tri-,tetra- and penta peptides
IL125926A0 (en) Compounds related to the amidinium family pharmaceutical compositions containing them and uses thereof
DE69203551T2 (de) Biologisch abbaubarer Copolyester von 4-Hydroxyprolin und diesen enthaltende pharmazeutische Zusammensetzung.
KR890701571A (ko) 4h-3, 1-벤즈옥사진-4-온 화합물 및 세린 프로테아제 억제를 위한 그의 약학 조성물
DK0918795T3 (da) Antiangiogene lægemidler til behandling af cancer, arthritis og retinopati
HUP0003475A2 (hu) Neutrofil-elasztáz gátló hatású pirrolo-pirrolon-származékok, eljárás előállításukra, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények
BR9707321A (pt) Dihidrobenzofurano e compostor correlatos úteis como agentes antinflamatórios
KR920701180A (ko) 4h-3,1-벤즈옥사진-4-온 화합물 및 그의 엘라스타아제 저해용 약학조성물
JP2021130656A (ja) ペプチド合成法
ATE116855T1 (de) 3-amino-epsilon-caprolactam enthaltende pharmazeutische zusammensetzungen zur verbesserung des lernvermögens und des gedächtnisses.
EP0934952A3 (en) Peptides containing an N-substituted glycine residue
IL98854A0 (en) Salts derived from 26-(dialkylaminoalkyl-sulphonyl)pristinamycin iib and pharmaceutical compositions containing them
Stöckel et al. Specific Inhibitors of Aminopeptidase P: Peptides and Pseudopeptides of 2-Hydroxy-3-Amino Acids
EP1032585A4 (en) DEOXYHYPUSIN REAGENT AND PEPTIDE
KR890000770B1 (ko) 프롤린 유도체의 제법

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8305123-5

Effective date: 19930406

Format of ref document f/p: F